“…The clinical phenotype of the visual disorders associated with both mutations, CSNB with G90D and RP with G90V, must be a consequence of differences in the dark-inactive structural conformation of the mutant receptor, which is thermally unstable in the case of the G90V mutation. This lower stability, alone or in combination with the formation of altered activation photointermediates upon illumination (29), could affect the rhodopsin cycle of intermediates, altering the normal rhodopsin turnover and prompting receptor malfunction and accumulation, which could trigger photoreceptor cell death associated with RP.…”